Browse our catalogue of products

Use any term of the related virus lineage (combine with commas)

224 products displayed

Ref-SKU Type Product Description ICTV Taxonomy Virus name Strain Isolate Product Grading Availability Product Risk Group Provider Cost per Access (Academics) More info Add to Cart
006V-03024 Virus rLCMV/LASV-GP(Josiah)-delGlycan15 Infectious cell culture supernatant of a recombinant LCMV virus expressing Lassa (strain Josiah) glycoprotein, glycan 15 defficient. Lymphocytic choriomeningitis mammarenavirus Lymphocytic choriomeningitis virus Arenaviridae Silver In stock RG2 UNIBAS 480€ View all details on this product . . .
Free access available
006V-03026 Virus rLCMV/WE-GP (+ Glycan 5) Glc5 is introduced in LCMV-GP thus mimicking LASV glycosylation. rLCMV+Glc5 is ≥100-fold less sensitive to KL25 or WEN3 neutralization than WT virus. Lymphocytic choriomeningitis mammarenavirus Lymphocytic choriomeningitis virus Silver In stock RG2 UNIBAS 480€ View all details on this product . . .
Free access available
006V-03030 Virus rLCMV-Cl13/GP_F38L Infectious supernatant containing LCMV strain Clone 13 with a point mutation at glycoprotein Aa38 (phenylalanine to leucine), resulting in a loss of binding of the otherwise immunodominant and here mutated H-2Db-presented and H-2Kb-presented GP33-41 and GP34-41 CD8+ T cell epitopes, respectively, of C57BL/6 mice. Lymphocytic choriomeningitis mammarenavirus Lymphocytic choriomeningitis virus Platinum In stock RG2 UNIBAS 480€ View all details on this product . . .
Free access available
006V-03031 Virus rLCMV-Cl13/GP_N280D Infectious supernatant containing LCMV strain Clone 13 with a point mutation at glycoprotein Aa280 (asparagine to aspartic acid), resulting in a loss of binding of the otherwise immunodominant and here mutated H-2Db-presented GP276-286 CD8+ T cell epitope in C57BL/6 mice. Lymphocytic choriomeningitis mammarenavirus Lymphocytic choriomeningitis virus Platinum In stock RG2 UNIBAS 480€ View all details on this product . . .
Free access available
006V-03032 Virus rLCMV-Cl13/NP_N400S Infectious supernatant containing LCMV strain Clone 13 with a point mutation at nucleoprotein Aa400 (asparagine to serine), resulting in a loss of binding of the otherwise immunodominant and here mutated H-2Db-presented NP396-404 CD8+ T cell epitope in C57BL/6 mice. Lymphocytic choriomeningitis mammarenavirus Lymphocytic choriomeningitis virus Australia Platinum In stock RG2 UNIBAS 480€ View all details on this product . . .
Free access available
006V-02865 Virus rLCMV/Tamiami-GP Infectious cell culture supernatant of a recombinant LCMV virus expressing Tamiami glycoprotein. Lymphocytic choriomeningitis mammarenavirus Lymphocytic choriomeningitis virus Silver In stock RG2 UNIBAS 480€ View all details on this product . . .
Free access available
006V-03029 Virus rLCMV/LASV-GP(Josiah_K461G) LASV GP K461G gives the ability of the recombinant virus to persist longer in vivo Lymphocytic choriomeningitis mammarenavirus Lymphocytic choriomeningitis virus Silver In stock RG2 UNIBAS 480€ View all details on this product . . .
Free access available
007V-04731 Virus rLCMV-Cl13/GP_A39C
Reference Strain, Vaccinal strain
recombinant LCMV Cl13 with mutated glycoprotein (GP). The GP33 epitope was mutated: A39C Arenaviridae rLCMV-Cl13/GP_A39C Silver In stock RG2 UNIBAS 480€ View all details on this product . . .
Free access available
007V-04471 Virus Vaccinia_WR_33C Vaccinia WR expressing mini epitope 33C Vaccinia virus Vaccinia virus WR Silver In stock RG2 UNIBAS 480€ View all details on this product . . .
Free access available
007V-04424 Virus rLCMV-ARM/WE-GP LCMV Armstrong expressing the glycoprotein of strain WE Lymphocytic choriomeningitis mammarenavirus Lymphocytic choriomeningitis virus Silver In stock RG2 UNIBAS 480€ View all details on this product . . .
Free access available
006V-03429 Virus HIV-1_gp41-DIV
Antiviral resistant strain, Reference Strain
Mutant of HIV-1, mutated "LLSGIV"-motif in gp41: LLSDIV, conferring resistance to Fuzeon Human immunodeficiency virus 1 Human immunodeficiency virus type 1 Platinum In stock RG3 UNIBAS 2,000€ View all details on this product . . .
Free access available
006V-02658 Virus HIV-1_pr45I-47V-50V
Antiviral resistant strain
HIV-1 variant, infectious recombinant virus with specific mutations in the protease gene as indicated. These mutations confer resistance to specific HIV protease inhibitors and have been reported for emerging virus in vivo. Human immunodeficiency virus 1 Human immunodeficiency virus 1 Subtype B point-mutated recombinant Platinum In stock RG3 UNIBAS 2,000€ View all details on this product . . .
Free access available
006N-02565 Nucleic Acid pHIV-1_delta-Env Plasmid containing an NL4-3 based HIV-1 genome with a big deletion between SalI site (5785) and XhoI site (8887), leading to a deletion of the viral genes vpu,env, tat, rev. Also the "rev-response-element" RRE is missing, leading to a lack of expression also of the gag-pol genes Human immunodeficiency virus 1 Human immunodeficiency virus 1 laboratory isolate Platinum In stock No RG UNIBAS 675€ View all details on this product . . .
Free access available
006V-03430 Virus HIV-1_gp41-MIF
Reference Strain
Gp41 recombinant, carrying the "MIF" motif, typical for subtype AE, in the fusion domain of the subtype B prototype NL4-3 - for studying the fusion function Human immunodeficiency virus 1 Human immunodeficiency virus type 1 Platinum In stock RG3 UNIBAS 2,000€ View all details on this product . . .
Free access available
007N-04416 Nucleic Acid pHIV-1_gp41-MIF
Reference Strain
Gp41 recombinant, carrying the "MIF" motif, typical for subtype AE, in the fusion domain of the subtype B prototype NL4-3 - for studying the fusion function. Human immunodeficiency virus 1 Human immunodeficiency virus 1 Clade B Platinum In stock RG2 UNIBAS 675€ View all details on this product . . .
Free access available
006V-03094 Virus HIV-1_rt-D67N
Antiviral resistant strain
HIV-1 variant, infectious recombinant virus with specific mutations in the RT gene as indicated. These mutations confer resistance to specific HIV RT inhibitors and have been reported for emerging virus in vivo. Human immunodeficiency virus 1 Human immunodeficiency virus 1 Subtype B point-mutated recombinant Platinum Upon request RG3 UNIBAS 2,000€ View all details on this product . . .
Free access available
006V-03101 Virus HIV-1_rt-M184V
Antiviral resistant strain
HIV-1 variant, infectious recombinant virus with specific mutations in the RT gene as indicated. These mutations confer resistance to specific HIV RT inhibitors and have been reported for emerging virus in vivo. Human immunodeficiency virus 1 Human immunodeficiency virus 1 Subtype B point-mutated recombinant Platinum Upon request RG3 UNIBAS 2,000€ View all details on this product . . .
Free access available
006V-03097 Virus HIV-1_rt-K103N
Antiviral resistant strain
HIV-1 variant, infectious recombinant virus with specific mutations in the RT gene as indicated. These mutations confer resistance to specific HIV RT inhibitors and have been reported for emerging virus in vivo. Human immunodeficiency virus 1 Human immunodeficiency virus 1 Subtype B point-mutated recombinant Platinum Upon request RG3 UNIBAS 2,000€ View all details on this product . . .
Free access available
006N-03079 Nucleic Acid pHIV-1_rt-K103N
Antiviral resistant strain
Plasmid contains the entire genome of HIV-1 with specific mutations in the reverse transcriptase gene, which can confer drug resistance to specific HIV-1 inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on reverse transcriptase inhibitors with virologic therapy failure. Human immunodeficiency virus 1 Human immunodeficiency virus 1 Subtype B recombinant Platinum In stock RG2 UNIBAS 675€ View all details on this product . . .
Free access available
006N-03080 Nucleic Acid pHIV-1_rt-M184V
Antiviral resistant strain
Plasmid contains the entire genome of HIV-1 with specific mutations in the reverse transcriptase gene, which can confer drug resistance to specific HIV-1 inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on reverse transcriptase inhibitors with virologic therapy failure. Human immunodeficiency virus 1 Human immunodeficiency virus 1 Subtype B recombinant Platinum In stock RG2 UNIBAS 675€ View all details on this product . . .
Free access available
006V-03423 Virus HIV-1_pr-L33F HIV-1 variant carrying a point mutation, which has been reported in the context of antiretroviral therapy Human immunodeficiency virus 1 Human immunodeficiency virus type 1 Platinum In stock RG3 UNIBAS 2,000€ View all details on this product . . .
Free access available
006V-03424 Virus HIV-1_pr-V82A
Antiviral resistant strain
HIV-1 recombinant, resistant to various HIV protease inhibitors Human immunodeficiency virus 1 Human immunodeficiency virus type 1 Platinum In stock RG3 UNIBAS 2,000€ View all details on this product . . .
Free access available
006V-03425 Virus HIV-1_pr-L63P
Reference Strain
This recombinant HIV-1 variant contains a common polymorphism, which has been described as increasing viral replication in the presence of fitness-reducing Pr mutations Human immunodeficiency virus 1 Human immunodeficiency virus type 1 Platinum In stock RG3 UNIBAS 2,000€ View all details on this product . . .
Free access available
006V-03427 Virus HIV-1_pr-M46I Clonal HIV-1 variant observed in vivo after protease inhibitor treatment Human immunodeficiency virus 1 Human immunodeficiency virus type 1 Platinum In stock RG3 UNIBAS 2,000€ View all details on this product . . .
Free access available
006V-03428 Virus HIV-1_gp41-GIV
Reference Strain
HIV-1 recombinant with a Fuzeon-sensitive gp41 protein, carrying the "LLSGIV" motif Human immunodeficiency virus 1 Human immunodeficiency virus type 1 Platinum In stock RG3 UNIBAS 2,000€ View all details on this product . . .
Free access available

catalogue

biobank

Portal

EVAg

purchase

buy

order

price

cost

shipping

shipment

experiment

research

laboratory

viral

virus

Filter by provider:

Cost per access

ranges from 480 to 4,400